Home

Bliss Gvs Pharma Ltd PE Ratio

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

PE

20.5

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Bliss GVS Pharma Ltd is 20.5 as of 15 Jan 09:47 AM .
  • The P/E Ratio of Bliss GVS Pharma Ltd changed from 10.7 on March 2020 to 15.6 on March 2024 . This represents a CAGR of 7.83% over 5 years.
  • The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 161 as of 15 Jan 09:39 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Bliss GVS Pharma Ltd

No data available

Company Fundamentals for Bliss GVS Pharma Ltd

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Share Price

₹ 161

-2.70 (-1.65%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025163.7
13 Jan 2025157.5
10 Jan 2025160.5
09 Jan 2025167
08 Jan 2025174.9
07 Jan 2025177.3
06 Jan 2025166.85
03 Jan 2025178.45
02 Jan 2025174.65
01 Jan 2025177.55

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Bliss GVS Pharma Ltd

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Bliss GVS Pharma Ltd1724
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Bliss GVS Pharma Ltd Explained

``

1724

Market cap

63

Earnings

20.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Bliss GVS Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Bliss GVS Pharma Ltd

No data available

* All values are in %

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Bliss GVS Pharma Ltd News Hub

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po

Read more

2024-10-18 00:00:00

Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter

Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024

Read more

2024-10-25 00:00:00

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme

Read more

2024-10-04 00:00:00

Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority

In a regulatory filing made on Saturday, the company informed that its manufacturing facilities loca

Read more

2024-11-25 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bliss GVS Pharma Ltd

What is the current PE Ratio of Bliss GVS Pharma Ltd?

The Current PE Ratio of Bliss GVS Pharma Ltd is 20.49 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Bliss GVS Pharma Ltd last year?

The PE Ratio of Bliss GVS Pharma Ltd was 10.48 last year, now the PE ratio is 20.49, showing a year-on-year growth of 95.5%.

What does the PE Ratio of Bliss GVS Pharma Ltd indicate about its stock?

The PE Ratio of Bliss GVS Pharma Ltd is 20.49. This ratio indicates that investors are willing to pay 20.49 times the earnings per share for each share of Bliss GVS Pharma Ltd.

What is the PE Ratio Growth of Bliss GVS Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bliss GVS Pharma Ltd grew by 95.5% whereas, the EPS ratio grew by 17.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions